Alba Ardèvol

1.4k total citations
16 papers, 500 citations indexed

About

Alba Ardèvol is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Alba Ardèvol has authored 16 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Alba Ardèvol's work include Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Alba Ardèvol is often cited by papers focused on Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Alba Ardèvol collaborates with scholars based in Spain and Switzerland. Alba Ardèvol's co-authors include Càndid Villanueva, Salvador Augustín, Rafael Bañares, Joan Genescà, Juan Carlos García‐Pagán, Jaime Bosch, Agustı́n Albillos, José Luís Calleja, Annalisa Berzigotti and Francisco Mesonero and has published in prestigious journals such as Hepatology, Journal of Hepatology and European Journal of Clinical Investigation.

In The Last Decade

Alba Ardèvol

15 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Ardèvol Spain 7 401 394 178 102 39 16 500
Ming-Hung Tsai Taiwan 12 373 0.9× 323 0.8× 233 1.3× 45 0.4× 35 0.9× 21 598
C Bataille Belgium 11 438 1.1× 349 0.9× 182 1.0× 38 0.4× 19 0.5× 16 516
Gyanranjan Rout India 12 293 0.7× 266 0.7× 107 0.6× 12 0.1× 20 0.5× 15 368
Barry Schlansky United States 10 196 0.5× 149 0.4× 243 1.4× 46 0.5× 10 0.3× 17 401
J Chesta Chile 12 616 1.5× 514 1.3× 248 1.4× 76 0.7× 50 1.3× 28 745
Éric Barrière France 9 286 0.7× 206 0.5× 162 0.9× 56 0.5× 14 0.4× 19 381
Marilyne Debette‐Gratien France 11 209 0.5× 161 0.4× 81 0.5× 64 0.6× 12 0.3× 29 363
Jaime Bosch Spain 10 909 2.3× 741 1.9× 466 2.6× 53 0.5× 32 0.8× 17 989
Didier Lebrec France 11 401 1.0× 290 0.7× 174 1.0× 65 0.6× 13 0.3× 14 465
Maureen Whitsett United States 9 157 0.4× 161 0.4× 101 0.6× 30 0.3× 44 1.1× 20 345

Countries citing papers authored by Alba Ardèvol

Since Specialization
Citations

This map shows the geographic impact of Alba Ardèvol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Ardèvol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Ardèvol more than expected).

Fields of papers citing papers by Alba Ardèvol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Ardèvol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Ardèvol. The network helps show where Alba Ardèvol may publish in the future.

Co-authorship network of co-authors of Alba Ardèvol

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Ardèvol. A scholar is included among the top collaborators of Alba Ardèvol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Ardèvol. Alba Ardèvol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Alvarado‐Tápias, Edilmar, Anna Brujats, Ángela Puente, et al.. (2024). Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trial. Hepatology. 82(1). 140–154. 6 indexed citations
2.
Ardèvol, Alba, Víctor Sapena, Edilmar Alvarado‐Tápias, et al.. (2024). Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes. Liver International. 44(8). 1971–1989. 4 indexed citations
3.
Sarrias, Maria‐Rosa, Alba Ardèvol, Ramón Bartolí, et al.. (2023). Systematic review of the role of calprotectin in cirrhosis. European Journal of Clinical Investigation. 54(2). e14111–e14111. 3 indexed citations
4.
Masnou, Helena, Alba Ardèvol, Montserrat Giménez, et al.. (2022). Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study. Gastroenterología y Hepatología. 46(4). 288–296. 1 indexed citations
5.
Alvarado‐Tápias, Edilmar, Anna Brujats, Marta Guix, et al.. (2022). Carvedilol plus Simvastatin modulates systemic inflammation in cirrhosis with portal hypertension and non-response to B-blockers: randomised double-blind study. Journal of Hepatology. 77. S91–S91. 2 indexed citations
6.
Masnou, Helena, Alba Ardèvol, Maria‐Rosa Sarrias, et al.. (2022). Prevalence and outcomes of acute-on-chronic liver failure among cirrhotic patients admitted for an acute decompensation. Gastroenterología y Hepatología (English Edition). 45(6). 424–431.
7.
Masnou, Helena, Alba Ardèvol, Maria‐Rosa Sarrias, et al.. (2021). Prevalence and outcomes of acute-on-chronic liver failure among cirrhotic patients admitted for an acute decompensation. Gastroenterología y Hepatología. 45(6). 424–431. 3 indexed citations
8.
Alvarado‐Tápias, Edilmar, Alba Ardèvol, Oana Pavel, et al.. (2020). Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. Journal of Hepatology. 73(4). 829–841. 36 indexed citations
9.
Ardèvol, Alba, Edilmar Alvarado‐Tápias, Anna Brujats, et al.. (2020). Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation. Digestive and Liver Disease. 52(9). 1017–1025. 9 indexed citations
10.
Ardèvol, Alba, Gemma Ibáñez‐Sanz, Carles Aracil, et al.. (2017). Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first‐line therapies. Hepatology. 67(4). 1458–1471. 44 indexed citations
11.
Villanueva, Càndid, Isabel Graupera, Carles Aracil, et al.. (2017). A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology. 65(5). 1693–1707. 55 indexed citations
12.
Berzigotti, Annalisa, Agustı́n Albillos, Càndid Villanueva, et al.. (2016). Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study. Hepatology. 65(4). 1293–1305. 236 indexed citations
13.
Graupera, Isabel, Oana Pavel, Virginia Hernández–Gea, et al.. (2015). Relative adrenal insufficiency in severe acute variceal and non‐variceal bleeding: influence on outcomes. Liver International. 35(8). 1964–1973. 7 indexed citations
14.
Alvarado, Edilmar, Oana Pavel, Alba Ardèvol, et al.. (2015). P0216 : Influence of previous decompensation of cirrhosis on hyperdynamic circulation and response to β-blockers in primary prophylaxis of variceal bleeding. Journal of Hepatology. 62. S387–S387. 1 indexed citations
15.
Cerini, Federica, Ferràn Torres, Ángela Puente, et al.. (2015). Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study. Hepatology. 62(2). 575–583. 91 indexed citations
16.
Planella, Montserrat, Montserrat Teixidó, Alba Ardèvol, et al.. (2009). ESTUDIO PROSPECTIVO DE LA INCIDENCIA DE ANEMIA FERROPÉNICA POST HEMORRAGIA DIGESTIVA ALTA. VALORACIÓN DE FACTORES PREDICTIVOS. RESULTADOS PRELIMINARES. Gastroenterología y Hepatología. 32(3). 245–245. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming-Hung Tsai Breakdown of academic impact, for papers by C Bataille Breakdown of academic impact, for papers by Gyanranjan Rout Breakdown of academic impact, for papers by Barry Schlansky Breakdown of academic impact, for papers by J Chesta Breakdown of academic impact, for papers by Éric Barrière Breakdown of academic impact, for papers by Marilyne Debette‐Gratien Breakdown of academic impact, for papers by Jaime Bosch Breakdown of academic impact, for papers by Didier Lebrec Breakdown of academic impact, for papers by Maureen Whitsett
Rankless by CCL
2026